Chandra Bhagat Pharma Ltd IPO Message Board (Page 1)

Dear Small
Sold 4 lot at 51.8
one lot holding, Now placed order at 51

Selling pressure now active , exit if any hold

Dear Raja
You Sold your 5 lot or Hold , Listing bellow Expected

Sold @ 52.10 one lot.

SOLD @ 52

All the best to all for a good listing!

Dear Small
I got 5/8

Dear Small
Rs 1.5 to 2.5 listing premium possible.

0/2 ( No allotment )

Allotted 1 lot. Amount debited from bank.

Listing May be On 13th Feb ?,In Last FPO and Janu Corp also List before tentative date
So Keep Touch Top IPO Site

Name of the company Chandra Bhagat Pharma Limited
Scrip Code : 542934
Symbol :CBPL
ISIN No:.INE07QQ01016


Listing Possible Tomorrow ?

Listing is on 14th...
Confirm by chittorgarh.

https://linkintime.co.in/IPO/public-issues.html link to check allotment

Tomorrow allotment..

I got amount deduction message from Bank. So allotment done.

Cbc pharma grey Mkt premium 2/- Buyer

Ahmedabad

how / from where we got this premium details.

Please don't apply in this.
HNI will not go above 3 times.

Don't go by track record. See the subscription and then apply.

I take risk and applied in CBC also for 1 lot

We should not compare a 10cr IPO with a 4cr IPO. 1.5times NII subscription in 10cr IPO is more than 3times NII in 4cr IPO. and there is LM with good track record who can play vital role on listing day.

NII show good response and may give good return in long term

Listing game milna chahiye....sme bahut kam log long term hold karte hain...

Please don't apply unless HNI subscribes more than 3 times.

Hni is oversubscribed 3 times

Sorry it is 1.50 times and not 3
Type mistake

Transway techno gave 10 % listing gain for small investors and SME will give normally same return.
CBC may do well as rightly NII have good response.

Dear Small
Eps for 2019 Mar is 1.17 pe is 43
Eps 0.46 as on July 19 and pe 110
RONW IS 4.71 as March 19 and July 1.84 (after issuing bonus shares at 7:1)
Nav as on July 19 is 25 against issue price of 51
Peer group Earum Pharma trading at 0.84 pe and Vishali Pharma 24 pe trading much lower than Candra is coming at pe of 110 (As on July 19)
Shareholder Fund is 14 Cr. (July 19)
Long term Debt is 9 Cr. and short term debt is 17Cr.
Debt is two times more than shareholder fund which is quite high.
Debt/Equity Ratio is 2.05 and it will reduce to 1.25 after issue. DRHP 168
Litigation by company is 2 (DRHP 168)
Litigation against company is 4 (involves 2 Dishonour cheque involves 27 lakh and 2.4 lakh
other 2 cases involves 11 lakh and 38 lakh.
Pending Litigation (drhp 170)
4 out of 3 is against Govt. of India. Other litigation (DRHP 170 TO 179)
Dear Small
Lot of litigation against company but amount involves is not much.
Drhp 170 to 179 no time to read other litigation
LM is Beeline so i will apply. Because so for three issues handled and all listing positive.
Since Sme stock dont look financial and other things, we need listing gain only.
That may happen i think so.
I will take risk and apply 2 application.

Very true
When beeline sure investors will earn

NII is giving good response. CBC has done awareness for IPO and market become good today. Long term good

NII is rocking Now

WAIT TILL 6TH ON LAST DAY OF IPO CLOSING

May be NII have long term strategy as HepA product will hv big demand and improve profit